A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod

Microglia activation, an indicator of central nervous system inflammation, is believed to contribute to the pathology of Huntington’s disease. Laquinimod is capable of regulating microglia. By targeting the translocator protein, (11)C-PBR28 PET-CT imaging can be used to assess the state of regional...

Descripción completa

Detalles Bibliográficos
Autores principales: Roussakis, Andreas-Antonios, Gennaro, Marta, Gordon, Mark Forrest, Reilmann, Ralf, Borowsky, Beth, Rynkowski, Gail, Lao-Kaim, Nicholas P, Papoutsou, Zoe, Savola, Juha-Matti, Hayden, Michael R, Owen, David R, Kalk, Nicola, Lingford-Hughes, Anne, Gunn, Roger N, Searle, Graham, Tabrizi, Sarah J, Piccini, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069663/
https://www.ncbi.nlm.nih.gov/pubmed/37020532
http://dx.doi.org/10.1093/braincomms/fcad084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069663/
https://www.ncbi.nlm.nih.gov/pubmed/37020532
http://dx.doi.org/10.1093/braincomms/fcad084

Ejemplares similares